Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

738
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
738
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

608
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

562
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
562
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

755
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
755

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrochemically Induced Reactivity of Ru-Arene Complexes Supported By Triarylphosphine Ligands.

Inorganic chemistry·2026
Same author

Editorial Comment on "From Lichtleiter to Laser: A 200-Year Odyssey of Transurethral Resection of Bladder Tumors".

Urology·2026
Same author

Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.

Journal of the National Cancer Institute·2026
Same author

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study.

World journal of urology·2026
Same author

Lateral thinking: the Carrion modified mini-jupette sling.

The journal of sexual medicine·2025
Same author

Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort study.

Journal of inflammation (London, England)·2025
Same journal

Opportunities, Challenges, and Perspectives for Equity and Capacity Building in Robot-ic Urological Surgery in Africa.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Staged Buried Oral Mucosal Strip Urethroplasty for Long-Segment Post-Hypospadias Urethral Strictures: Achieving Functional Recovery and Distal Meatal Preservation.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Suture versus Sutureless Retroperitoneal Robot-assisted Partial Nephrectomy using Veriset™ Hemostatic Patch: A Propensity Score Matched Comparative Analysis from a Single Centre.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Conversion of Total Intracorporeal Ileal Conduit to Studer Orthotopic Ileal Neobladder Using the Kangduo 2000 Robotic System.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Anencephaly Defects Do Not Alter Macroscopic Development of the Ureterovesical Junction in Human Fetuses.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Clitoris Anatomy Applied to Aesthetic, Reconstructive and Transgender Surgery: A Narrative Review.

International braz j urol : official journal of the Brazilian Society of Urology·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.3K

Partial Priapism Treated with Pentoxifylline.

Meghan A Cooper1, Rafael E Carrion2, Christopher Yang2

  • 1Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.

International Braz J Urol : Official Journal of the Brazilian Society of Urology
|September 25, 2015
PubMed
Summary
This summary is machine-generated.

Pentoxifylline effectively treated partial priapism, a rare condition involving corpus cavernosum thrombosis. This case report highlights pentoxifylline

More Related Videos

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.9K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

Related Experiment Videos

Last Updated: Apr 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.3K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.9K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Partial priapism is a rare urological condition characterized by thrombosis in a single corpus cavernosum.
  • Etiology is often unclear, with potential links to trauma or specific activities.

Observation:

  • A case of partial priapism in a 26-year-old male is presented.
  • The condition involved thrombosis within the proximal corpus cavernosum.

Findings:

  • Successful treatment was achieved using pentoxifylline, a phosphodiesterase inhibitor.
  • Pentoxifylline is also used for conservative management of Peyronie's disease.

Implications:

  • This report suggests pentoxifylline's utility in managing partial priapism.
  • Its anti-fibrogenic and anti-thrombotic properties may benefit patients with this condition.